The Life Sciences Innovative Manufacturing Fund (LSIMF)
The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to build resilience for future health emergencies and capitalise on the UK’s world-leading research and development capabilities. The fund will enhance and accelerate affordable access to mature, new and emerging Life Sciences products for both pandemic and non-pandemic scenarios.
LSIMF will provide up to £520 million in capital grants for investment in the manufacture of human medicines and medical technology (including diagnostics, and MedTech products).
This is a new fund from previous UK Government Life Sciences manufacturing funds.
LSIMF is open to all eligible companies, including previous manufacturing grant recipients, as long as the application is for a different project.
Projects with a total cost (including capital expenditure) of at least £8 million are eligible to apply.
Our typical intervention rate is between 10-20% of your total project costs. For example, for a project with a total cost of £100m, the typical grant awarded might be £10-20m.
You are required to submit an Expression of Interest (EOI) with a summary of your project which will be used to assess your project’s eligibility and can be submitted at any time whilst the fund is open to applications. If your project is deemed eligible, you will be invited to submit an application.
- Applications will undergo assessment in quarterly rounds until all the funding has been allocated:
- Round 1 will open for applications on 30 October 2024 and close on 29 November 2024
- Round 2 will open on 01 February 2025 and close on 28 February 2025
- Round 3 will open on 01 May 2025 and close on 30 May 2025
- Round 4 will open on 01 August 2025 and close on 29 August 2025.
Subsequent application rounds will open on a quarterly basis until all the funding has been allocated.
To ensure the fund meets its objectives and adapts to market activity, the scheme will undergo an annual review, therefore the criteria and application windows are subject to change. This page will be updated regularly with details on future application rounds.